Intuitive Surgical (ISRG) Receives FDA Letter Following Facility Inspection
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
FDA Form 483 on Intuitive Surgical (ISRG) is 'Benign' - Canaccord Genuity
June 26, 2013 10:55 AM EDTCanaccord Genuity reiterated a Buy rating and $527 price target on Intuitive Surgical (NASDAQ: ISRG) Wednesday amid the Form 483 filing from the FDA saying it is benign.
Canaccord Genuity analyst Jason Mills said "Based on our conversations with management last night, we believe... More
